Skip to content
Hi-Doctor

How to Get Retatrutide Online in Lithuania

Retatrutide is an experimental treatment currently in clinical trials. It is not yet approved by the European Medicines Agency (EMA) and is therefore not legally available in Lithuania or anywhere in the EU.

23 April 2026
How to Get Retatrutide Online in Lithuania

How to Get Retatrutide Online in Lithuania

Many individuals in Lithuania are looking for advanced solutions for weight management, and the experimental drug Retatrutide has caught significant attention. However, it's crucial to understand that Retatrutide is not currently approved for weight-loss prescription in the EU and is still undergoing clinical trials. Therefore, Hi-Doctor does not offer Retatrutide at this time. This article will explain what Retatrutide is, why it isn't readily available, and guide you toward EU-approved, proven weight-loss treatments that you can access today through an EU-licensed doctor.

What is Retatrutide, and why isn't it a normal option yet?

Retatrutide is an investigational medication being developed for weight management. It's a triple-agonist, meaning it activates three different hormone receptors: GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon. This multi-targeted approach has shown promising results in clinical trials, suggesting it could lead to significant weight loss.

Despite its potential, Retatrutide is still in Phase 3 clinical trials globally. In the EU, the European Medicines Agency (EMA) has not yet reviewed or approved Retatrutide for use, meaning it cannot be legally prescribed or sold in Lithuania or any other EU country. The US FDA also has not approved it. Because it is unapproved, obtaining Retatrutide from unregulated online sources carries significant safety risks, including the possibility of counterfeit products, incorrect dosages, and lack of medical oversight, which can be dangerous to your health.

Proven weight-loss medications available online today

While Retatrutide is not an option, several highly effective, EMA-approved weight-loss medications are available for prescription through EU-licensed doctors. These treatments have undergone rigorous testing and are proven to be safe and effective when used under medical supervision:

  • Ozempic (semaglutide): Primarily approved for type 2 diabetes, Ozempic is also prescribed off-label for weight management in suitable patients, working by mimicking a natural hormone that regulates appetite.
  • Wegovy (semaglutide): This is a higher-dose formulation of semaglutide specifically approved for chronic weight management, suitable for individuals with obesity or overweight with at least one weight-related comorbidity.
  • Mounjaro (tirzepatide): A dual GLP-1 and GIP receptor agonist, Mounjaro is approved for type 2 diabetes and is also increasingly prescribed for weight loss, offering significant efficacy.
  • Saxenda (liraglutide): An earlier GLP-1 receptor agonist, Saxenda is approved for weight management and involves daily injections, suitable for those who meet specific BMI criteria.

How to get a weight-loss prescription online in Lithuania

Hi-Doctor makes it straightforward and safe to access EU-approved weight-loss treatments. Our process is designed to connect you with an EU-licensed doctor for a personalized assessment:

  1. Complete an online questionnaire: Start by filling out a secure, confidential medical questionnaire (2–3 minutes) detailing your health history and weight-loss goals.
  2. EU-licensed doctor review: An EU-licensed doctor will individually review your case. This consultation costs a flat €25, and if the doctor determines treatment is not appropriate, your €25 is automatically refunded.
  3. Receive your REMPE prescription: If approved, you will receive a REMPE electronic prescription (Spanish standard, valid EU-wide) within 24 hours. This will be a downloadable PDF in your account and sent via email.
  4. Pick up at any EU pharmacy: Your prescription is valid at any pharmacy in any EU country under cross-border prescription directive 2011/24/EU. Simply print it or show it on your phone.

Why choose Hi-Doctor over unregulated peptide sellers

When considering weight management, safety and legitimate medical oversight are paramount. Choosing Hi-Doctor ensures you receive care from EU-licensed doctors who conduct individual case reviews. We provide real medications through auditable, RGPD-compliant chat, with electronic prescriptions valid at any EU pharmacy. With over 50,000 patients served and a 4.8 Trustpilot rating, Hi-Doctor offers a secure and regulated alternative to the risks associated with 'research chemicals' or grey-market peptide vendors who operate without medical supervision.

Frequently asked questions

Is Retatrutide legal to buy online in Lithuania?

No, Retatrutide is not legally approved for sale or prescription in Lithuania or any EU country. Purchasing it online from unregulated sources is illegal and carries significant health risks.

When will Retatrutide be available by prescription?

Retatrutide is currently in Phase 3 clinical trials. It will only be available by prescription after it receives full approval from regulatory bodies like the European Medicines Agency (EMA), which could take several years.

What's the closest approved alternative to Retatrutide?

Mounjaro (tirzepatide) is currently the closest approved alternative, as it is also a dual GLP-1 and GIP receptor agonist, similar to Retatrutide's multi-targeted approach, though Retatrutide also targets glucagon.

How much does an online weight-loss consultation cost?

At Hi-Doctor, an online consultation with an EU-licensed doctor for weight-loss treatment costs a flat €25. This fee is refunded if the doctor determines treatment is not appropriate for you.

Can I use a Hi-Doctor prescription at any pharmacy?

Yes, all Hi-Doctor prescriptions are REMPE electronic prescriptions, which are valid at any pharmacy in any EU country under the cross-border prescription directive 2011/24/EU.

HI-DOCTOR NEWSLETTER

We'll tell you when we add new treatments.

At most 2 emails a month. No spam. Updates on online health, EU telemedicine, and clinical guides signed by licensed doctors.